Related Experiment Video

Updated: Apr 19, 2026

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
13:25

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish

Published on: May 15, 2021

6.9K

RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway

Hongyi Liu1, Peng Li, Bing Li

  • 1Department of Surgical Oncology, General Hospital of Chinese People's Liberation Army, No. 28, Fuxing Rd, Beijing, 100853, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|December 31, 2014
PubMed

Insights

Raf kinase inhibitor protein (RKIP) is downregulated in cisplatin-resistant gastric cancer cells. Overexpressing RKIP enhances sensitivity to cisplatin, potentially through the NF-κB/Snail pathway, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer remains a significant global health challenge.
  • Cisplatin resistance is a major obstacle in gastric cancer treatment.
  • Understanding the molecular mechanisms underlying cisplatin resistance is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the expression levels of Raf kinase inhibitor protein (RKIP) in gastric cancer cell lines.
  • To explore the role of RKIP in modulating the sensitivity of gastric cancer cells to cisplatin.
  • To elucidate the signaling pathways involved in RKIP-mediated cisplatin response.

Main Methods:

  • Western blotting to detect RKIP expression in SGC-7901 and SGC-7901/DDP cells.
  • RNA interference (siRNA) to suppress RKIP expression in SGC-7901 cells.
  • MTT assay to assess cell viability after RKIP manipulation and cisplatin treatment.
  • Flow cytometry to evaluate apoptosis in response to RKIP changes and cisplatin.
  • Western blotting to analyze NF-κB and Snail expression.

Main Results:

  • RKIP expression was significantly downregulated in cisplatin-resistant SGC-7901/DDP cells compared to SGC-7901 cells.
  • Suppression of RKIP increased cell viability and reduced apoptosis in cisplatin-treated SGC-7901 cells.
  • Overexpression of RKIP decreased cell viability and increased apoptosis in cisplatin-treated SGC-7901/DDP cells.
  • RKIP suppression promoted NF-κB expression, while RKIP overexpression inhibited Snail expression.

Conclusions:

  • RKIP expression is inversely correlated with cisplatin resistance in gastric cancer.
  • Overexpression of RKIP enhances gastric cancer cell sensitivity to cisplatin.
  • The NF-κB/Snail signaling pathway is implicated in RKIP's role in cisplatin response.
  • Targeting RKIP may represent a novel therapeutic strategy for overcoming cisplatin resistance in gastric cancer.

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.8K

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
788
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K